HemaCare Corp. Raises $2.41 Million
HemaCare Corp., a Sherman Oaks provider of blood-related products and services, said it raised $2.41 million from the exercise of warrants that allowed the holders to purchase HemaCare common stock at $3.50 per share.
The company said the 695,272 warrants that were exercised represented 99% of the 700,000 warrants issued along with an offering of HemaCare common stock in October.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
